Objective-Factors released by perivascular adipose tissue (PVAT) disrupt coronary endothelial function via phosphorylation of endothelial NO synthase by protein kinase C (PKC)-␤. However, our understanding of how PVAT potentially contributes to coronary disease as a complication of obesity/metabolic syndrome (MetS) remains limited. The current study investigated whether PVAT-derived leptin impairs coronary vascular function via PKC-␤ in MetS. Methods and Results-Coronary arteries with and without PVAT were collected from lean or MetS Ossabaw miniature swine for isometric tension studies. Endothelial-dependent vasodilation to bradykinin was significantly reduced in MetS.
A dipose tissue is widely accepted to be an active endocrine and paracrine organ. As a signaling organ, the production of adipose-derived cytokines (adipokines) has been well documented to influence many physiological and pathophysiologic conditions. 1 Importantly, adipokine production has been shown to influence key pathogenic mediators of atherogenesis, 1 including chemotaxis, 2 inflammation, 3 and endothelial function. 4 -6 Although adipokines have been proposed to be a molecular link between obesity and cardiovascular disease, 1 the exact relationship remains uncertain.
Recent studies implicate adipose tissue that normally surrounds large coronary arteries, ie, perivascular/periadventitial adipose tissue (PVAT), as a local source of adipokines that contributes to the initiation of vascular dysfunction and atherosclerotic disease. [7] [8] [9] [10] [11] This contention is supported by data indicating that coronary atherosclerotic plaques primarily occur in the larger epicardial arteries encased by PVAT, 10 as well as other findings illustrating a positive association between epicardial PVAT volume and the severity of coronary artery disease. 9, 12 A recent investigation from Greif et al 9 documented that PVAT volume, hypoadiponectinemia, and inflammation represent the strongest risk factors for the presence of coronary atherosclerosis. Importantly, our laboratory has demonstrated that factors released by PVAT in normal lean animals significantly impair coronary endothelial-dependent vasodilation and NO production via protein kinase C (PKC)-␤-dependent phosphorylation of endothelial NO synthase at the inhibitory amino acid residue Thr 495 . 13, 14 These findings establish a mechanistic link between local cardiac PVAT and coronary endothelial function, which is widely accepted to be the inciting event in the pathogenesis of atherosclerosis. 15, 16 However, the degree to which alterations in local PVAT adipokine signaling influence coronary vascular dysfunction/disease (ie, endothelial dysfunction) in the metabolic syndrome (MetS) has yet to be examined.
The purpose of the present investigation was to test the hypothesis that augmented PVAT-derived leptin exacerbates underlying coronary endothelial dysfunction in the MetS via a PKC-␤-dependent pathway. We tested this hypothesis directly in vitro by manipulation of PVAT leptin signaling in the absence of systemic leptin. This hypothesis is supported by recent evidence that epicardial PVAT from patients with MetS contains activated macrophages and expresses significantly higher levels of potentially atherogenic adipokines, including a Ϸ7-fold increase in leptin expression. 7 In addition, our laboratory has demonstrated that hyperleptinemia alone markedly impairs coronary endothelial function, 5 which we propose occurs via a PKC-␤-dependent pathway. 14 Findings from this investigation offer novel insight into the potential role of PVAT-derived leptin in the increased prevalence and severity of coronary disease in the setting of the MetS. 17 
Methods

Ossabaw Miniature Swine Model of Metabolic Syndrome
Lean Ossabaw swine (total nϭ11 animals, malesϭ8 and femaleϭ3) were fed standard chow (Ϸ2200 kcal per day; 5L80; Purina) containing (in % kcal) 18% protein, 71% complex carbohydrates, 11% fat, and 0% cholesterol. MetS Ossabaw swine (total nϭ15, malesϭ8 and femalesϭ7) were fed Ϸ8000 kcal per day with modified chow (5B4L; Purina) containing (in % kcal) 17% protein, 20% complex carbohydrates, 20% fructose, and 43% fat (lard and hydrogenated soybean and coconut oils). MetS diet was supplemented with 2% cholesterol and 0.7% sodium cholate by weight. 18 The duration of the diet period was 20 weeks for both lean and MetS swine. No differences in vascular responses were noted between male and female swine. Protocols for plasma parameters and quantification of the degree of coronary atherosclerosis were conducted as previously described. 19, 20 
Functional Assessment of Isolated Epicardial Coronary Rings
Isolated coronary artery studies were performed for both experimental groups as previously described. 13, 14 Briefly, left anterior descending coronary arteries were dissected out with naturally surrounding PVAT (average weight of PVAT arteries was 0.45Ϯ0.03 g per ring for both lean and MetS swine) (Figure 1 ). Arteries were then cut into 3-mm rings, and the PVAT was either left intact or carefully dissected. Clean and PVAT containing arteries from lean and MetS swine were then mounted in organ baths for isometric tension studies. Arteries were taken to optimal length (3.9Ϯ0.4 g tension on average) and precontracted with the thromboxane A 2 mimetic U46619 (1 mol/L). Vascular function was assessed by the addition of graded concentrations of the bradykinin (0.1 nmol/L to 10 mol/L, nϭ7 lean; nϭ9 MetS) or sodium nitroprusside (1.0 to 0.1 mmol/L, nϭ4 lean; nϭ6 MetS) to the tissue bath. Additional bradykinin concentration responses were conducted in MetS coronary arteries with and without PVAT in the presence of a recombinant, pegylated leptin receptor antagonist (1 mol/L, nϭ4; Protein Laboratories) 21 or the PKC-␤-specific inhibitor ruboxistaurin (Eli Lilly and Company, Indianapolis, Ind) (1 mol/L, nϭ6). The leptin receptor antagonist is a mutant leptin analogue that functions as a competitive inhibitor. Further proof of principle studies were performed with leptin (30 ng/mL)Ϯruboxistaurin (1 mol/L) in coronary arteries from lean swine without PVAT (nϭ4). Data are reported as the percentage of relaxation for arterial rings from individual animals; 100% relaxation was defined as the resulting tension following the administration of nitroglycerin (20 mol/L), ie, equivalent to the loss of all active tension developed in response to U46619.
Western Blot and RT-PCR Analyses
Western blotting was performed as previously described. 14 Briefly, tissues were isolated, frozen in liquid N 2 , and stored at Ϫ80°C. PVAT was homogenized, centrifuged, and the resulting supernatants were collected for analysis. Equivalent amounts of protein were loaded onto 15% acrylamide gels for electrophoresis and blotting with a primary antibody against leptin (1:1000; Abcam). Immunoreactivity was visualized using an enhanced chemiluminescence Western blotting detection kit (GE Healthcare) and quantified by scanning densitometry (Bio-Rad Quantity One 1-D Analysis Software). Real-time PCR was performed using total RNA isolated from PVAT of both lean and MetS swine as previously described. 22 Primers specific for human leptin were used (SA Biosciences), and expression was normalized by threshold cycle number for each group.
Immunohistochemistry
Fixed artery segments were embedded in paraffin and cross-sectioned (Zymed Laboratories, Inc.). Tissue sections were rehydrated, and antigen retrieval (0.1 mol/L citrate buffer) was performed prior to blocking. Tissue sections were then incubated overnight at 4°C with polyclonal antibodies directed against leptin receptor (ObR) (1:100; Abcam). Sections were then rinsed and incubated with an antirabbit biotinylated antibody followed by a tertiary streptavidin peroxidase conjugate (Zymed Laboratories, Inc.). Tissue sections were developed (5-minute exposure to 3-amino-9-ethyl-carbazole) and counter stained with hemotoxylin. Photomicrographs were obtained using standard light microscopy (Nikon Spot camera system).
PKC Activity Assay
PKC-␤ enzymatic activity from coronary arteries was assessed using a PKC activity assay (Assay Designs). Experimental groups included PVAT-exposed MetS arteries with and without ruboxistaurin (1 mol/L) pretreatment and lean arteries pretreated with exogenous leptin (30 ng/mL; nϭ3 animals for each group). Crude protein extracts were then prepared and measured at equal loading concentrations. PKC activity was measured by spectroscopy as indicated by the manufacturer.
Statistical Analyses
Data are presented as meanϮSE for n number of animals. For isometric tension studies, a 2-way ANOVA was used to test the effects of the perivascular adipose (factor A) and various drugs (factor B) on coronary dilator responsiveness. A t test was used in specific cases (eg, lean versus MetS) to compare phenotypic data, EC 50 values, and data from Western blot analyses (Sigma Stat 3.0). When statistical differences were found with ANOVA, a Student Newman-Keuls multiple comparison test was performed. The criterion for statistical significance was PϽ0.05 in all tests. 
Results
Phenotype of Lean and MetS Ossabaw Miniature Swine
Compared with their lean counterparts, MetS swine exhibited a 49% increase in body weight (kg), 90% increase in fasting glucose, 662% increase in total cholesterol, 140% increase in triglyceride levels, and a 17% increase in blood pressure and heart rate. Importantly, MetS swine also exhibited greater atherosclerotic arterial wall coverage and percent luminal stenosis (Table) . Figure 1 illustrates representative coronary arteries with and without PVAT isolated from lean ( Figure 1A ) and MetS ( Figure 1B) swine. The volume of coronary PVAT was typically larger in hearts from MetS versus lean swine. However, PVAT volume was not experimentally quantified.
Epicardial PVAT and Coronary Endothelial Function in MetS
Baseline pretension averaged Ϸ3.9Ϯ0.4 g for coronary artery rings from lean and MetS swine with and without PVAT (Pϭ0.44). Active tension developed in response to 1 mol/L U46619 was significantly decreased from 10.5Ϯ0.8 g in lean to 6.9Ϯ0.7 g in MetS arteries without PVAT (Pϭ0.004). Active tension development was unaffected by the presence of PVAT in coronary arteries from both lean and MetS swine (Pϭ0.41 for MetS and 0.90 for lean). The presence of PVAT had no significant effect on endothelial-dependent vasodilation to bradykinin (Figure 2A ) or endothelial-independent vasodilation to sodium nitroprusside ( Figure 2B ) in coronary arteries obtained from lean swine. In contrast, induction of the MetS alone resulted in significant endothelial dysfunction that was markedly exacerbated by the presence of PVAT (Figure  2A and 2C) . In particular, the EC 50 value for bradykinin-induced relaxation in MetS coronary arteries without PVAT was 9.6Ϯ4.3 nmol/L compared with 1.3Ϯ0.5 nmol/L for lean (PϽ0.05). PVAT-derived factors markedly exacerbated underlying endothelial dysfunction in MetS arteries as evidenced by the approximate log-order rightward shift in bradykinin EC 50 (from 9.6Ϯ4.3 to 92.3Ϯ32.8 nmol/L, PϽ0.05). In addition, bradykinin-mediated vasodilation was significantly attenuated in the concentration range of 1 nmol/L to 10 mol/L (PϽ0.001; Figure 2C ). Importantly, the maximal dilator response to bradykinin (10 mol/L) was also significantly attenuated by MetS PVAT (from 87Ϯ7 to 59Ϯ6%, PϽ0.001). MetS PVAT modestly attenuated of endothelialindependent relaxation to sodium nitroprusside in the concentration range of 100 to 320 nmol/L (PϽ0.01). However, the maximal response and EC 50 were unaffected ( Figure 2D ).
Epicardial PVAT-Derived Leptin and Coronary Endothelial Dysfunction in MetS
Western blot analysis demonstrated that induction of the MetS increased epicardial PVAT leptin protein Ϸ50Ϯ10% relative to PVAT from lean swine (PϽ0.05, nϭ4 lean and MetS animals each) ( Figure 3A) . ␤-Actin protein expression was not different in PVAT from lean versus MetS swine (gel not shown, Pϭ0.60). RT-PCR revealed no significant difference in leptin gene expression between lean (threshold cy- cleϭ42.4) and MetS (threshold cycleϭ42.5) swine (Pϭ0.9). Importantly, administration of a recombinant, pegylated ObR antagonist (200 ng/mL) significantly improved endothelialdependent dilation to bradykinin (from 10 nmol/L to 10 mol/L) in MetS coronary arteries with PVAT (PϽ0.001; Figure 3B ). Inhibition of leptin signaling also augmented the maximal dilator response to bradykinin (from 59Ϯ12 to 88Ϯ6%, PϽ0.001) and tended to improve bradykinin EC 50 from 153Ϯ60 to 29Ϯ14 nmol/L (PϽ0.09). Additional immunohistochemistry studies confirmed expression of the ObR in coronary arteries from lean and MetS swine. Coronary ObR expression was located predominantly in the coronary endothelium ( Figure 4A ). Selectivity of the ObR antibody (Abcam) was confirmed by Western blot analysis. Additional Western blot analyses also showed that coronary ObR expression was significantly elevated in coronary arteries obtained from MetS swine (nϭ4; Figure 4B ).
Leptin and MetS PVAT Induce Coronary Endothelial Dysfunction via a PKC-␤
We found that PKC activity was markedly increased in MetS coronary arteries exposed to PVAT relative to PVAT exposed arteries from lean swine ( Figure 5A ). This increase in activity was reversed by pretreatment with the PKC-␤ inhibitor ruboxistaurin (1 mol/L), and was similar to the elevation of PKC activity observed following the administration of exogenous leptin (30 ng/mL) to lean coronary arteries without PVAT. Additional "proof of principle" studies determined that acute administration of leptin (30 ng/mL) attenuated endothelial-dependent dilation to bradykinin (from 0. dilation to bradykinin (range 10 nmol/L to 10 mol/L) in MetS coronary arteries with PVAT (PϽ0.001; Figure 5D ). This effect was evidenced by a decrease in the EC 50 from 139.4Ϯ48.8 to 22.1Ϯ11.9 nmol/L (PϽ0.05) and increase in the maximal vasodilatory response from 54Ϯ8 to 77Ϯ6% (PϽ0.05). Other studies also demonstrated that ruboxistaurin completely restored leptin-induced coronary endothelial dysfunction in coronary arteries without PVAT from lean swine ( Figure 5B ).
Discussion
Recent investigations have implicated PVAT in the initiation and development of atherosclerotic disease. [7] [8] [9] [10] [11] 13, 14 However, the degree to which alterations in local PVAT adipokine expression influence coronary endothelial dysfunction (ie, a precursor of atherosclerosis) in the MetS has not been established. Accordingly, this investigation was designed to examine the effects of MetS epicardial PVAT on coronary endothelial function and elucidate the primary PVAT-derived adipokine and signaling pathway involved. The novel findings of this study include: (1) epicardial PVAT from lean swine has little effect on coronary endothelial-dependent or independent dilation; (2) coronary arteries from MetS swine display significant endothelial dysfunction that is markedly exacerbated by PVAT; (3) MetS increases expression of coronary ObR and is associated with elevated epicardial PVAT leptin protein, whereas leptin gene expression is unaltered; (4) administration of a recombinant, pegylated leptin antagonist essentially reverses the effect of MetS PVAT on coronary endothelial-dependent dilation; (5) PKC activity is elevated in MetS coronary arteries exposed to PVAT, and this effect is reversed by ruboxistaurin; (6) acute administration of leptin alone impairs coronary endothelial function and increases PKC-␤ activity; and (7) inhibition of PKC-␤ improves coronary endothelial-dependent dilation in the presence of MetS PVAT. Taken together, these results suggest that epicardial PVAT-derived leptin exacerbates coronary endothelial dysfunction in MetS primarily via a PKC-␤-dependent signaling pathway.
Results from the present study are the first to identify PVAT-derived leptin and PKC-␤ signaling in MetS-induced coronary endothelial dysfunction, which is recognized to be an inciting event in the initiation and development of atherosclerotic disease. 15, 16 Our findings are consistent with recent clinical studies documenting increased epicardial PVAT volume as a risk factor for coronary atherosclerosis 9, 12 and implicate the local production and paracrine release of potentially atherogenic adipokines from PVAT in MetS-induced coronary artery disease. The effect of MetS PVAT on coronary endothelial-dependent and endothelial-independent dilation is consistent with recent data from our laboratory, which demonstrated that PVAT-derived factors significantly diminish endothelial NO production via PKC-␤-dependent, site-specific phosphorylation of endothelial NO synthase at the inhibitory Thr 495 residue. 13, 14 However, these earlier findings, which were documented in coronary arteries from lean, healthy dogs, are in contrast to the present data from lean Ossabaw swine, in which PVAT had no effect on coronary endothelial function (Figure 2A ). We propose that these disparate findings are largely related to differences in adipokine expression between canines and swine. Although we have currently been unable to directly quantify coronary PVAT leptin concentration in Ossabaw swine, previous studies have documented a 3-fold difference in plasma leptin concentrations in lean canines (Ϸ6 ng/mL) 23 versus lean Ossabaw swine (Ϸ2 ng/mL). Importantly, our present Western blot analysis suggests that increased trafficking/secretion of leptin from adipocytes resulted in elevated leptin protein in MetS PVAT (Figure 3) , which is consistent with the increase in epicardial adipose leptin expression observed in patients with coronary artery disease. 7 The observation that inhibition of leptin signaling essentially mitigates the effect of MetS PVAT on coronary endothelial-dependent dilation ( Figure  3B ) supports the functional relevance of the increase in PVAT leptin expression. Furthermore, additional data demonstrating that exogenous leptin administration (30 ng/mL; Figure 5B ) impairs coronary endothelial function further supports the potential role of leptin in the pathogenesis of MetS-induced coronary disease. Importantly, we found that exogenous leptin reduced endothelial-dependent dilation in clean coronary arteries from both lean and MetS swine. Thus, we found no evidence of coronary "leptin resistance" in this study, which is in contrast to our previous study in chronically high-fat-fed dogs. 23 Clearly, future studies are needed to more fully characterize the production and release of leptin from coronary PVAT and to establish a direct causal role for local PVAT-derived adipokines in coronary atherogenesis.
Leptin-induced activation of PKC-␤-dependent signaling is supported by the ruboxistaurin-sensitive increase in PKC activity in MetS coronary arteries exposed to PVAT and in clean coronary arteries from lean swine exposed to leptin ( Figure 5A ). We propose that the increase in PKC activity in MetS coronary arteries is mediated by elevated local production of leptin in PVAT (Figure 3) , as well as augmented coronary ObR density (Figure 4) . The functional coupling of leptin and PKC is significant, because PKC-␤ has been suggested to play a critical role in obesity-induced endothelial dysfunction. 24, 25 Results from the Bohlen laboratory demonstrated that inhibition of PKC-␤ substantially augmented endothelial NO production in obese Zucker rats. 24 Although our data directly implicate PKC-␤ as an essential component of coronary endothelial leptin signaling, characterization of the intermediate signaling cascade remains to be completed. Of note, ObR signaling is associated with both janus kinase-2 (JAK2)-dependent and JAK2-independent pathways, including the signal transducer and activator of transcription-3, phosphatidylinositol 3-kinase, mitogen-activated protein kinase, adenosine monophosphate activated kinase, and mammalian target of rapamycin pathways. These pathways act coordinately to form a network that fully mediates leptin response. 26, 27 However, recent studies also indicate that phosphatidylinositol 3-kinase 28 and Ras homolog gene family, member A (RhoA), 29 are involved with leptin-induced activation of PKC-␤, as well as the proatherogenic/inflammatory nature of leptin. Further studies are needed to elucidate the precise mediators and pathways involved in this cascade.
The current findings highlight local PVAT-derived leptin as a novel potential contributor to the initiation of coronary atherogenesis in the setting of the MetS. Furthermore, our data are among the first to demonstrate functional coupling between PVAT and PKC-␤ signaling that supports the "outside to inside" signaling paradigm for PVAT-derived factors in the pathogenesis of coronary artery disease. 30 Future studies are needed to address the overall pathophysiologic relevance of PVAT-derived factors, in particular leptin, to MetS-induced coronary vascular dysfunction/disease, which, at present, is limited by our understanding of how periadventitial factors effectively communicate with the endothelium.
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